Dr. Ken Uchino, MD

Dr. Uchino practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Uchino's NPI, 1164498747, was assigned on February 24, 2006. Dr. Uchino graduated from New York University School of Medicine in 1997. Dr. Uchino holds Ohio license 35.093750.

Dr. Uchino's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Uchino's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Uchino is also affiliated with Avon Hospital at Richard E. Jacobs Campus. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Uchino to 3 more medical groups and 2 clinical labs, each named with a free account. Dr. Uchino's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Uchino practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Dr. Uchino's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dmand AI has Dr. Uchino's licenses on file in 3 states: Ohio, Florida and Pennsylvania.

CMS data shows 163 Medicare services from Dr. Uchino across 7 procedure codes in 2024, for 210 Medicare patients. Medicare paid $11,402 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 210 Medicare patients who saw Dr. Uchino in 2024. The largest group is 65 to 74, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Uchino's median patient age at 65, with 52% women.

In 2024, Dr. Uchino wrote 105 Medicare Part D claims for 37 patients. 77% of them were for generic drugs. CMS names the drug for 37 of them, across 2 drugs with 11 or more claims each, at $15,366 in total drug cost. In 2023, CMS named 76 claims across 4 drugs.

Dr. Uchino accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Uchino as offering telehealth.

Dmand AI links 151 papers to Dr. Uchino, published from 2009 to 2025. 2021 was the busiest year, with 12. The most frequent topics are Stroke, Brain Ischemia and Thrombolytic Therapy. Dr. Uchino has published most often in J Stroke Cerebrovasc Dis. Dr. Uchino's most frequent co-authors are Dolora R. Wisco, Irene L. Katzan, MD and Andrew Blake Buletko.

Dmand AI links Dr. Uchino to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Ischemic Stroke, Stroke and Cerebrovascular Disorders.

CMS Open Payments shows 16 general payments to Dr. Uchino from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. Genentech, Inc. paid the most, $4,398. It also lists 12 research payments totaling $1,286 in 2018.

Dr. Uchino graduated from New York University School of Medicine in 1997.